Abstract:Hyperglycemia is a key determinant for development of diabetic retinopathy (DR). Inadequate glycemic control exacerbates retinopathy, while normalization of glucose levels delays its progression. In hyperglycemia, hexokinase is saturated and excess glucose is metabolized to sorbitol by aldose reductase via the polyol pathway. Therapies to reduce retinal polyol accumulation for the prevention of DR have been elusive because of low sorbitol dehydrogenase levels in the retina and inadequate inhibition of aldose reductase. Using systemic and conditional genetic inactivation, we targeted the primary facilitative glucose transporter in the retina, Glut1, as a preventative therapeutic in diabetic male and female mice. Unlike WT diabetics, diabetic Glut1 +/– mice did not display elevated Glut1 levels in the retina. Furthermore, diabetic Glut1 +/– mice exhibited ameliorated ERG defects, inflammation, and oxidative stress, which was correlated with a significant reduction in retinal sorbitol accumulation. Retinal pigment epithelium-specific reduction of Glut1 did not prevent an increase in retinal sorbitol content or early hallmarks of DR. However, like diabetic Glut1 +/– mice, reduction of Glut1 specifically in the retina mitigated polyol accumulation and diminished retinal dysfunction and the elevation of markers for oxidative stress and inflammation associated with diabetes. These results suggest that modulation of retinal polyol accumulation via Glut1 in photoreceptors can circumvent the difficulties in regulating systemic glucose metabolism and be exploited to prevent DR. SIGNIFICANCE STATEMENT Diabetic retinopathy affects one-third of diabetic patients and is the primary cause of vision loss in adults 20-74 years of age. While anti-VEGF and photocoagulation treatments for the late-stage vision threatening complications can prevent vision loss, a significant proportion of patients do not respond to anti-VEGF therapies, and mechanisms to stop progression of early-stage symptoms remain elusive. Glut1 is the primary facilitative glucose transporter for the retina. We determined that a moderate reduction in Glut1 levels, specifically in the retina, but not the retinal pigment epithelium, was sufficient to prevent retinal polyol accumulation and the earliest functional defects to be identified in the diabetic retina. Our study defines modulation of Glut1 in retinal neurons as a targetable molecule for prevention of diabetic retinopathy.

Reducing Akt2 in retinal pigment epithelial cells causes a compensatory increase in Akt1 and attenuates diabetic retinopathy

Aberrant Akt2 signaling in the RPE may contribute to retinal fibrosis process in diabetic retinopathy

Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy

Protein Kinase C-δ Mediates Neuronal Apoptosis in the Retinas of Diabetic Rats via the Akt Signaling Pathway

The involvement of ACO3 protein in diabetic retinopathy through the PI3k/Akt signaling pathway

Acteoside inhibits high glucose-induced oxidative stress injury in RPE cells and the outer retina through the Keap1/Nrf2/ARE pathway

Diabetes and high-glucose could upregulate the expression of receptor for activated C kinase 1 in retina

KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy

CD200R Promotes High Glucose-Induced Oxidative Stress and Damage in Human Retinal Pigment Epithelial Cells by Activating the mTOR Signaling Pathway

Loss of Pleckstrin Homology Domain and Leucine-Rich Repeat Protein Phosphatase 2 Has Protective Effects on High Glucose-Injured Retinal Ganglion Cells Via the Effect on the Akt–GSK–3β–Nrf2 Pathway

Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy

Knockdown of HCK promotes HREC cell viability and inner blood-retinal barrier integrity by regulating the AMPK signaling pathway

Prostaglandin F2α protects against pericyte apoptosis by inhibiting the PI3K/Akt/GSK3β/β-catenin signaling pathway

REDD1-dependent GSK3β dephosphorylation promotes NF-κB activation and macrophage infiltration in the retina of diabetic mice

Pathogenic Role of Diabetes-Induced PPAR-α Down-Regulation in Microvascular Dysfunction.

Retinal Src Homology Region 2-Containing Protein Tyrosine Phosphatase 2 Silencing Alleviates Diabetic Retinopathy Via Suppressing Inflammatory Response and Oxidative Stress by Regulating Yes-associated Protein 1 Activity

Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy

RKIP Negatively Regulates the Glucose Induced Angiogenesis and Endothelial-Mesenchymal Transition in Retinal Endothelial Cells.

Retinylamine Benefits Early Diabetic Retinopathy in Mice*

Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy

VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway